Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
The Sabin SIF team- Devendra Gnawali, Clifford Kamara, Diana Kizza, Jonas Mbwangue, Helene Mambu-Ma-Disu, Mike McQuestion, Sandra Keller and Sabin Executive Vice-President Ciro de Quadros- met in Johannesburg from 31 July to 4 Aug for a SIF Sabin Meeting and the 9th International Rotavirus
Diana Kizza, a Health Economist, is the Sustainable Immunization Financing Program (SIF) Senior Program Officer for the Sabin Vaccine Institute program in the Eastern African countries of Ethiopia, Kenya and Uganda.
A second news article covering the two-day SIF-sponsored July 15-16 event, the "Second Sub-regional Symposium for Parliamentarians on Sustainable Immunization Financing” from Sri Lanka's 'Daily News' was published today, giving highlights of the event:
A Sri Lankan news publication just published an article covering the jointly sponsored event by both the Sri Lankan Health Ministry and the Sabin Vaccine Institute, taking place both today and tomorrow in Colombo.